Ticker
XERSCompany Name
XERIS BIOPHARMA HOLDINGS INCSector
HealthcareIndustry
BiotechnologyExchange
NASDAQDate | Book Value per Share | Shareholders Equity | Share Factor | Weighted Average Shares |
---|---|---|---|---|
6/30/2025 | $ -0.12 | $ -19.3M | 1 | 159.46M |
3/31/2025 | $ -0.23 | $ -35.13M | 1 | 152.45M |
12/31/2024 | $ -0.2 | $ -29.61M | 1 | 146.77M |
9/30/2024 | $ -0.19 | $ -28.32M | 1 | 148.99M |
6/30/2024 | $ -0.13 | $ -19.29M | 1 | 148.35M |
3/31/2024 | $ -0.07 | $ -9.18M | 1 | 140.51M |
12/31/2023 | $ -0.05 | $ -6.78M | 1 | 137.67M |
9/30/2023 | $ 0.03 | $ 3.87M | 1 | 138.06M |
6/30/2023 | $ 0.1 | $ 13.64M | 1 | 137.34M |
3/31/2023 | $ 0.22 | $ 30.05M | 1 | 137.14M |
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
Equity / (Shares WA * Share Factor)
(=) BVPS
BVPS for XERIS BIOPHARMA HOLDINGS INC is calculated as follows: Equity [ $ 14.34M ] / (Shares WA [ 46.15M ] * Share Factor [ 1 ])
(=) BVPS [ $ 0.31 ]
Minimum
Mar 31, 2025
Maximum
Dec 31, 2021
Average
Median
filtered constituents | 4K |
---|---|
min | $ -30.1 |
max | $ 46.91 |
average | $ 10.29 |
median | $ 6.08 |
std | $ 12.46 |